Related Experiment Video
Updated: Nov 12, 2025
09:36
Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
Published on: June 23, 2022
3.7K
Iron Status May Not Affect Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
Jiahao Cai1, Xiong Chen2, Hongxuan Wang1
1Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Frontiers in Genetics
|March 22, 2021
Summary
This study found no causal link between iron status and amyotrophic lateral sclerosis (ALS) risk. Interventions targeting iron levels may not be effective for preventing ALS.
Area of Science:
- Neurodegenerative diseases
- Metabolic disorders
- Genetic epidemiology
Background:
- Observational studies suggest a link between elevated iron status and increased amyotrophic lateral sclerosis (ALS) risk.
- Investigating a potential causal relationship is crucial for identifying novel ALS prevention targets.
Purpose of the Study:
- To determine the causal effect of iron status on the incidence of amyotrophic lateral sclerosis (ALS) using Mendelian randomization (MR).
Main Methods:
- Utilized a large two-sample MR design with genome-wide association study (GWAS) data for iron status (n=48,972) and ALS (n=80,010).
- Employed inverse variance weighted (IVW) as the primary analysis, alongside sensitivity analyses (weighted median, MR-Egger, MR-PRESSO) to assess pleiotropy.
Main Results:
- No significant causal association was observed between genetically predicted iron status (iron, ferritin, transferrin saturation, transferrin) and ALS risk in conservative or liberal analyses.
- Sensitivity analyses did not detect significant pleiotropy, supporting the robustness of the findings.
Conclusions:
- The study provides no evidence for a causal effect of iron status on amyotrophic lateral sclerosis (ALS) risk.
- Targeting iron status for ALS prevention strategies may not be a practical approach.
